Vimarsana
Biggest News Aggregation in the World

Database Syst Rev News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Database Syst Rev. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Database Syst Rev Today - Breaking & Trending Today

Mundipharma announces European approval of REZZAYO® (rezafungin) for the treatment of Invasive Candidiasis in adults - Vimarsana News

Mundipharma announces European approval of REZZAYO® (rezafungin) for the treatment of Invasive Candidiasis in adults

Mundipharma today announced rezafungin (rezafungin acetate) has been approved in the European Union (EU) for the treatment of invasive candidiasis in adults. The approval by the European Commission (EC) follows the positive opinion of the Committee...

How to Treat: Maternal birth injuries - Vimarsana News

How to Treat: Maternal birth injuries

On 1 October 2022, the Accident Compensation (Maternal Birth Injury and Other Matters) Amendment Act 2022 came into effect, resulting in the biggest change to ACC coverage of injuries in recent history. Now, birthing parents can access ACC funding for maternal birth injuries that were previously excluded from coverage. This article, written by Melissa Davidson, outlines what this means for birthing parents and all healthcare providers in New Zealand

Tobacco Quitlines May Help Exclusive Vapers Quit: An Analysis of Data From an Employer-Sponsored Quitline - Vimarsana News

Tobacco Quitlines May Help Exclusive Vapers Quit: An Analysis of Data From an Employer-Sponsored Quitline

Preventing Chronic Disease (PCD) is a peer-reviewed electronic journal established by the National Center for Chronic Disease Prevention and Health Promotion. PCD provides an open exchange of information and knowledge among researchers, practitioners, policy makers, and others who strive to improve the health of the public through chronic disease prevention.

Source: cdc.gov
Nature Medicine Publishes Discovery of New Pharmacological Class by Aelis Farma, Phase 2a Study of F - Vimarsana News

Nature Medicine Publishes Discovery of New Pharmacological Class by Aelis Farma, Phase 2a Study of F

Cannabis use disorder (CUD) affects over 14 million individuals in the USDespite the urgent need, there are no FDA-approved medications to treat CUD; behavioral treatments have shown limited benefitAEF0117 is the first of a new pharmacologic class, type 1 cannabinoid receptor signaling-specific inhibitors (CB1-SSi),...

Using Randomized Controlled Trials to Estimate the Effect of Community Interventions for Childhood Asthma - Vimarsana News

Using Randomized Controlled Trials to Estimate the Effect of Community Interventions for Childhood Asthma

Preventing Chronic Disease (PCD) is a peer-reviewed electronic journal established by the National Center for Chronic Disease Prevention and Health Promotion. PCD provides an open exchange of information and knowledge among researchers, practitioners, policy makers, and others who strive to improve the health of the public through chronic disease prevention.

Source: cdc.gov